Sterility Testing: Crucial safety measures exclusively in pharmaceutical

2018-05-21 12:11:45

According to a new report published by Reports Monitor titled, “Sterility Testing Market by Product, Test, and Application: Global Opportunity Analysis and Industry Forecast, 2017–2025,” the sterility testing market was valued at XX million in 2016, and is projected to reach at XX million by 2025, growing at a CAGR of XX% from 2017 to 2025.

Sterilisation is any procedure using which microorganisms are effectively eradicated from any surface, instrument of material. Sterility testing is one of the major aspects of the healthcare sector that assures the purity and safety of a product or equipment. The process is intense & hard and carried out by skilled professional precisely in order to fend off the false negative results. The specific requirements to engage sterility testing procedures as an official test and to evaluate the suitability are monitored under the good manufacturing practices guidelines. 

Know More| Request for PDF Brochure @

Rising prevalence of chronic disorders such as HIV and cancer that are easily transmitted from patient to the healthy people through the contaminated substances is one of the vital aspects leading the market growth. According to CDC in 2015, out of every 10,000 exposure to infected blood transfusion approximately 9,250 transfusions showed transmission of the HIV. Furthermore, technical advanced, surging R&D activities in healthcare and other life science industries and rising geriatric population pertaining to the need of various advent of medication stimulates the growth of the market. However, stringent regulatory norms, time consuming approval procedures and huge cost of test may constrain the growth of the market. Swift adoption of improved technology, increasing need for sterility testing, well established healthcare infrastructure and presence of multiple giant pharmaceutical and biotechnological companies uplifts the growth of the sterility testing market in North America. 

The global sterility testing market is segmented on the basis of product type, by application, by test and region. Based on product type the market is divided into kits & reagents, services and instruments. In terms of test type the market is spilt into membrane filtration, direct inoculation and other sterility test. Depending upon application the market is categorized into medical device manufacturing, pharmaceutical & biological manufacturing and other applications. 

Competitive Landscape
Major players running in the market are Merck KGaA, Sartorius AG, Thermo Fisher Scientific, Inc., SGS S.A., BioMérieux SA, Wuxi AppTec, Charles River Laboratories International, Inc., Becton, Dickinson and Company, Rapid Micro Biosystems, Inc. and Avance Biosciences.

For instance, bioMérieux and Merck Millipore are known to be strong contender in the sterility testing market owing to their solid product pipeline. Also in order to improve the production capacity of its Lombard in the U.S. and Craponne in the France facilities bioMérieux SA is increasingly investing in the industrial application.

About Us:

We at Garner provide a comprehensive analysis by providing in-depth reports of the various market verticals. Our Mission is to provide a detailed analysis of the vast markets worldwide backed by rich data. Decision makers can now rely on our well-defined data gathering methods to get the correct and accurate market forecasting along with detailed analysis.

Contact Us:

Mr. Kevin Thomas


+1 513 549 5911 (US)

+44 203 318 2846 (UK)

Email: [email protected]

Related Press Releases